Triple Therapy of Dexamethasone, Palonosetron, and Fosaprepitant as PONV Prevention
Status:
Not yet recruiting
Trial end date:
2024-03-22
Target enrollment:
Participant gender:
Summary
As a preventive for postoperative nausea and vomiting in patients undergoing laparoscopic
gynecological surgery, we shall investigate the efficacy of the triple therapy of
dexamethasone, palonosetron, and fosaprepitant comparing to dual therapy of dexamethasone and
palonosetron.